FDA Wants To Boost Premium Intraocular Lenses By Creating New Endpoints
This article was originally published in The Gray Sheet
Executive Summary
FDA officials and American Academy of Ophthalmology experts discussed at a recent meeting the prospects of creating new endpoints for premium intraocular lenses that they hope can streamline the development process.